NEUROTROPE BIOSCIENCE, INC. (39) | Uncategorized (8)

Recent Contracts

Engagement Letter, dated June 14, 2021, by and between Synaptogenix, Inc. and Katalyst Securities LLC (Filed With SEC on June 16, 2021)
Statement of Work Agreement dated February 4, 2015, and effective as of October 1, 2014, between Neurotrope Bioscience, Inc. and BRNI (Filed With SEC on March 30, 2021)
Letter Agreement between the Neurotrope, Inc. and Neurosciences Research Ventures, Inc. regarding NRV Director Nominees, dated November 12, 2015 (assumed by Synaptogenix, Inc. on... (Filed With SEC on March 30, 2021)
Statement of Work Agreement between Neurotrope BioScience, Inc. and Blanchette Rockefeller Neurosciences Institute, dated November 12, 2015 (Filed With SEC on March 30, 2021)
Engagement Letter, dated January 20, 2021, by and between Synaptogenix, Inc. and Katalyst Securities LLC (Filed With SEC on January 22, 2021)
Tax Matters Agreement, dated as of December 6, 2020, by and between Neurotrope, Inc. and Synaptogenix, Inc (Filed With SEC on December 10, 2020)
Offer Letter, dated as of December 7, 2020, by and between Synaptogenix, Inc. and Alan J. Tuchman, Ph.D (Filed With SEC on December 10, 2020)
Form of Tax Matters Agreement by and between Neurotrope, Inc. and Neurotrope Bioscience, Inc (Filed With SEC on October 30, 2020)